Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell membrane and associated envelope components constitute the primary physical barrier between a microorganism and its environment. In bacteria, this complex structure typically includes the inner cytoplasmic membrane, a rigid peptidoglycan cell wall, and, in Gram-negative species, an outer membrane containing lipopolysaccharides (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). These components are vital for maintaining osmotic stability, regulating the transport of nutrients and waste, and facilitating signal transduction (Malanovic & Lohner, 2016, Pharmaceuticals). Because many of these structures, particularly the peptidoglycan layer, are unique to microbes and absent in mammalian cells, they represent ideal targets for selective toxicity in antimicrobial therapy (Kapoor et al., 2017, J Postgrad Med). Antibiotics like beta-lactams and glycopeptides interfere with cell wall assembly, while others like polymyxins and lipopeptides directly disrupt membrane integrity, leading to cell lysis and death (Kapoor et al., 2017, J Postgrad Med). In fungi, the cell membrane contains ergosterol, which is targeted by polyenes and azoles to alter permeability and inhibit growth (Odds et al., 2003, J Antimicrob Chemother). Targeting the cell envelope remains a cornerstone of treating infectious diseases, though the emergence of resistance mechanisms like modified target sites or efflux pumps presents ongoing therapeutic challenges.
Inhibition of peptidoglycan synthesis, disruption of membrane integrity, pore formation, inhibition of cell wall cross-linking, and alteration of membrane permeability.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and associated envelope components.